Hilo
It builds a wearable, Fitbit-style blood pressure health system designed to monitor hypertension without traditional arm cuffs.
Overview
Hilo develops a cuffless blood pressure health system positioned as a wearable alternative to traditional arm-cuff measurement. Its product is aimed at people managing hypertension and related cardiovascular risks, with a Fitbit-style form factor designed for more frequent monitoring. The company’s differentiation is its focus on replacing 145-year-old cuff technology with a continuous, consumer-friendly monitoring approach. Hilo raised a $19M Series B extension in July 2026, bringing total disclosed funding to $19M across the reported round.
Funding History
Hilo raises $19M Series B extension for Fitbit-style blood pressure health system: Can it replace 145-year-old cuff technology?
Frequently Asked Questions
- How much has Hilo raised in total?
- Hilo has raised a total of $19M across 1 funding round.
- What does Hilo do?
- Hilo develops a cuffless blood pressure health system positioned as a wearable alternative to traditional arm-cuff measurement. Its product is aimed at people managing hypertension and related cardiovascular risks, with a Fitbit-style form factor designed for more frequent monitoring. The company’s differentiation is its focus on replacing 145-year-old cuff technology with a continuous, consumer-friendly monitoring approach. Hilo raised a $19M Series B extension in July 2026, bringing total disclosed funding to $19M across the reported round.
- Where is Hilo headquartered?
- Hilo is headquartered in Neuchâtel, Switzerland.
Related Insights
A comprehensive analysis of Axiamatic's funding history, investors, competitive position, and growth trajectory in the Enterprise AI space.
A comprehensive analysis of Sage's funding history, investors, competitive position, and growth trajectory in the AI Healthcare space.
A comprehensive analysis of Listen Labs's funding history, investors, competitive position, and growth trajectory in the Enterprise AI space.